Thrombopoietin receptor agonists: ten years later
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were licensed in the US for treatment of immune thrombocytopenia (ITP) in 2008 and, since then, their use has progressively increased around the world; they are currently used in more than 100 countries. The six largest...
| Main Authors: | , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Ferrata Storti Foundation
2019-06-01
|
| סדרה: | Haematologica |
| גישה מקוונת: | https://haematologica.org/article/view/8925 |